Acme United CEO Walter Johnsen Discussed Growth Prospects For 2016
For today’s interview, we’re excited to sit down with Mr. Walter C. Johnsen, the Chairman and CEO of Acme United Corp (ACU – $17.29). 2015 was the seventh consecutive year of record performance for Acme United, and that trend has continued in the first quarter of 2016. So we’re very curious to find out how that growth was achieved and if record results are likely to be reached in following quarters.
Mr. Johnsen explains why he’s confident that 2016 will be a good year for Acme United. He first describes how Diamond Machining Technology (DMT), which was acquired in February of this year, could become a very profitable part of the Company.
In just two months after its acquisition, DMT has secured additional placement at a couple of major retailers. As a result, the production capacity will shortly be increased, and a second shift is being contemplated.
Next to DMT, Mr. Johnsen talks about why the Westcott brand of school and office products is performing well above last year. The CEO also discusses the excellent outlook for Camillus knives in the second half of 2016.
In addition, the interview touches upon Acme United’s first aid business. The major order from one of the largest retailers in the world for SmartCompliance kits is discussed, we discover which $600 million market the Company is trying to enter, and we find out that an order was recently placed by Saudi Airlines for first aid kits.
The interview also takes a look at the success of the Cuda fishing tools brand since its launch in 2014.
Finally, Mr. Johnsen provides details about the outlook of the Company’s three business segments – the United States, Canada and Europe. And he gives a summary of why he feels a long term investor should consider investing in Acme United today.
Access our interview by clicking the play button on the media player below,
or download our convenient transcript.
| || |
|Smallcaps.us Advice: Buy||Price Target: $40.98||Latest Company Report (pdf)|
|For important disclosures, please read our disclaimer.|